TY - JOUR
T1 - Maternal early-pregnancy vitamin D status is associated with maternal depressive symptoms in the Amsterdam Born Children and Their Development cohort
AU - Brandenbarg, J.
AU - Vrijkotte, T.G.M.
AU - Goedhart-de Wolf, G.
AU - van Eijsden, M.
PY - 2012
Y1 - 2012
N2 - OBJECTIVE: To examine low maternal vitamin D status as a potential risk factor for high levels of depressive symptoms in a pregnant population. METHODS: In the Amsterdam Born Children and Their Development cohort, maternal serum vitamin D (n = 4236) was measured during early pregnancy (median, 13 weeks) and labeled "deficient" (≤ 29.9 nM), "insufficient" (30-49.9 nM), "sufficient" (50-79.9 nM), and "normal" (≥ 80 nM). Maternal depressive symptoms were measured by the Center for Epidemiological Studies Depression Scale at 16-week gestation. The association of vitamin D status with high levels of depressive symptoms (Center for Epidemiological Studies Depression score ≥ 16) was assessed by multivariate logistic regression (final sample, 4101). RESULTS: Overall, 23% of women had vitamin D deficiency, and 21% of women had vitamin D insufficiency. Women with high levels of depressive symptoms (28%) had lower vitamin D concentrations than women with low levels of depressive symptoms (p <.001). After adjustment for constitutional factors, life-style and psychosocial covariates, and sociodemographic factors, vitamin D deficiency (odds ratio [OR], 1.48; 95% confidence interval [CI], 1.13-1.95) and insufficiency (OR, 1.44; 95% CI, 1.12-1.85) were significantly associated with high levels of depressive symptoms. Additional analyses revealed a linear trend, with an OR of 1.05 (95% CI, 1.02-1.08) for each 10-nM decrease in vitamin D status. CONCLUSIONS: In this study, low early-pregnancy vitamin D status was associated with elevated depressive symptoms in pregnancy. Further research, using a randomized controlled design, would be required to confirm the causality of this association and the potential benefits of higher vitamin D intake for psychosocial health.
AB - OBJECTIVE: To examine low maternal vitamin D status as a potential risk factor for high levels of depressive symptoms in a pregnant population. METHODS: In the Amsterdam Born Children and Their Development cohort, maternal serum vitamin D (n = 4236) was measured during early pregnancy (median, 13 weeks) and labeled "deficient" (≤ 29.9 nM), "insufficient" (30-49.9 nM), "sufficient" (50-79.9 nM), and "normal" (≥ 80 nM). Maternal depressive symptoms were measured by the Center for Epidemiological Studies Depression Scale at 16-week gestation. The association of vitamin D status with high levels of depressive symptoms (Center for Epidemiological Studies Depression score ≥ 16) was assessed by multivariate logistic regression (final sample, 4101). RESULTS: Overall, 23% of women had vitamin D deficiency, and 21% of women had vitamin D insufficiency. Women with high levels of depressive symptoms (28%) had lower vitamin D concentrations than women with low levels of depressive symptoms (p <.001). After adjustment for constitutional factors, life-style and psychosocial covariates, and sociodemographic factors, vitamin D deficiency (odds ratio [OR], 1.48; 95% confidence interval [CI], 1.13-1.95) and insufficiency (OR, 1.44; 95% CI, 1.12-1.85) were significantly associated with high levels of depressive symptoms. Additional analyses revealed a linear trend, with an OR of 1.05 (95% CI, 1.02-1.08) for each 10-nM decrease in vitamin D status. CONCLUSIONS: In this study, low early-pregnancy vitamin D status was associated with elevated depressive symptoms in pregnancy. Further research, using a randomized controlled design, would be required to confirm the causality of this association and the potential benefits of higher vitamin D intake for psychosocial health.
U2 - 10.1097/PSY.0b013e3182639fdb
DO - 10.1097/PSY.0b013e3182639fdb
M3 - Article
SN - 0033-3174
VL - 74
SP - 751
EP - 757
JO - Psychosomatic Medicine
JF - Psychosomatic Medicine
IS - 7
ER -